Author: Wu LL1, Lin ZK2, Weng HD3, Qi QF1, Lu J4, Liu KX5
Affiliation: <sup>1</sup>Department of Respiratory Medicine, Fuzhou Pulmonary Hospital, Fuzhou, People's Republic of China.
<sup>2</sup>Department of Rehabilitation, No. 175 Hospital of PLA, Zhangzhou, Fujian, People's Republic of China.
<sup>3</sup>Postgraduate Institute of Fujian Medical University, Fuzhou, People's Republic of China.
<sup>4</sup>Department of Medical Oncology, Fuzhou Pulmonary Hospital, Fuzhou, People's Republic of China.
<sup>5</sup>Department of Respiratory Medicine, The First Affiliated Hospital, Fujian Medical University, Fuzhou, People's Republic of China.
Conference/Journal: Int J Chron Obstruct Pulmon Dis.
Date published: 2018 Apr 17
Other:
Volume ID: 13 , Pages: 1239-1250 , Special Notes: doi: 10.2147/COPD.S159042. eCollection 2018. , Word Count: 243
Background: The effectiveness of meditative movement (tai chi, yoga, and qigong) on COPD remained unclear. We undertook a systematic review and meta-analysis to determine the effectiveness of meditative movement on COPD patients.
Methods: We searched PubMed, Web of Science, EMBASE, and the Cochrane Center Register of Controlled Trials for relevant studies. The methods of standard meta-analysis were utilized for identifying relevant researches (until August 2017), quality appraisal, and synthesis. The primary outcomes were the 6-minute walking distance (6MWD), lung function, and dyspnea levels.
Results: Sixteen studies involving 1,176 COPD patients were included. When comparing with the control group, the 6MWD was significantly enhanced in the treatment group (3 months: mean difference [MD]=25.40 m, 95% CI: 16.25 to 34.54; 6 months: MD=35.75 m, 95% CI: 22.23 to 49.27), as well as functions on forced expiratory volume in 1 s (FEV1) (3 months: MD=0.1L, 95% CI: 0.02 to 0.18; 6 months: MD=0.18L, 95% CI: 0.1 to 0.26), and FEV1 % predicted (3 months: 4L, 95% CI: 2.7 to 5.31; 6 months: MD=4.8L, 95% CI: 2.56 to 7.07). Quality of life for the group doing meditative movement was better than the control group based on the Chronic Respiratory Disease Questionnaire dyspnea score (MD=0.9 units, 95% CI: 0.51 to 1.29) and fatigue score (MD=0.75 units, 95% CI: 0.42 to 1.09) and the total score (MD=1.92 units, 95% CI: 0.54 to 3.31).
Conclusion: Meditative movement may have the potential to enhance lung function and physical activity in COPD patients. More large-scale, well-designed, multicenter, randomized controlled trials should be launched to evaluate the long-range effects of meditative movement.
KEYWORDS: COPD; meditative movement; meta-analysis; qigong; tai chi; yoga
PMID: 29713157 PMCID: PMC5909800 DOI: 10.2147/COPD.S159042